Oncology Views & News

Views and news in clinical oncology, research, cancer prevention, patient care and more.

Labels

  • ASCO15
  • Hematology Malignancies
  • GI Cancers
  • Lung Cancer
  • Breast Cancer
  • Cancer China
  • Biomarkers
  • Immunotherapy
  • EHA15
  • NCCN15
  • China Cancer Drugs
  • ELCC15

Saturday, February 28, 2015

  • 《Under the Dome》: Smog & Haze Documentary Film Gone Viral in China


  • Wednesday, February 25, 2015

  • P-GEMOX Might be the Best Regimen to Treat Extranodal NK/T Cell Lymphoma, So Far?


  • Tuesday, February 24, 2015

  • A State and Specialized Cancer Registration Network Finally Will be Established in China


  • Monday, February 23, 2015

  • Atrocious Cancer Assault: China's Cancer Incidence & Mortality Rates Top the World, Yet Countering Efforts Frail


  • Sunday, February 22, 2015

  • Nano-carried FOLFIRINOX regimen: A new way to fight pancreatic cancer


  • Thursday, February 19, 2015

  • The Latest Cancer Hospital Ranking in China


  • Newer Posts Older Posts Home
    Subscribe to: Posts (Atom)

    Search This Blog

    Popular Posts

    • At ASCO 2015, Dr. Shi Meets with Dr. Lynch to Discuss about Highlights in Lung Cancer and Icotinib
    • Immunotherapy Breakthrough in Advanced Melanoma Treatment, Biomarker Lacks--Dr. Jun Guo Discusses LBA1 at ASCO 2015
    • Target Therapy or Missed Target Therapy in Lung Cancer New Data? --Commentaries from Dr. Yi-Long Wu at ASCO 2015
    • Chinese Cancer Patients are Seeking the Best Chance for Cure, Globally
    • How to Overcome Drug Resistance to Target Therapy in Non Small Cell Lung Cancer?--Dr. Leona Horn's Interview at NCCN 2015

    Translate

    Blog Archive

    • ▼  2015 (42)
      • ►  July (13)
      • ►  June (17)
      • ►  April (1)
      • ►  March (4)
      • ▼  February (7)
        • 《Under the Dome》: Smog & Haze Documentary Film Gon...
        • P-GEMOX Might be the Best Regimen to Treat Extrano...
        • A State and Specialized Cancer Registration Networ...
        • Atrocious Cancer Assault: China's Cancer Incidence...
        • Nano-carried FOLFIRINOX regimen: A new way to figh...
        • The Latest Cancer Hospital Ranking in China
        • Anticancer Drugs Professional Committee was Organi...

    About Me

    Oncology China
    Views and news in clinical oncology, research, cancer prevention, patient care and more.
    View my complete profile

    Disclaimer

    The blog is designed primarily for use by qualified physicians, other medical professionals, researchers and scientists in oncology field. The information contained herein should NOT be used as anyway a substitute for the advice of a licensed physician or other licensed health care provider. The information provided here is for informational and educational purposes only. In no way should it be considered as offering medical advice. Please check with your physician for any consultation. All opinions expressed by quoted sources are their own and do not necessarily reflect the opinions of the author(s) of this blog. While every effort has been made to provide up to date, accurate information and in depth analysis, your view of this blog is solely at your own risk if you make any decisions based on the information in this blog. The blog may keep updating old posts and is not bound to explain or state any changes made.

    Total Pageviews

    Simple theme. Powered by Blogger.